DN
DNA Group (T.R.) Ltd.
DNA | TA
Overview
Corporate Details
- ISIN(s):
- IL0011038523
- LEI:
- Country:
- Israel
- Address:
- Shimon Hatars' 43, 6249245 Tel Aviv
- Website:
- N/A
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
DNA Group develops and markets technological solutions for defense and homeland security sectors.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2022-11-06 14:35 |
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
|
Hebrew (modern) | 149.0 KB | |
| 2021-07-29 21:13 |
Regulatory News Service
Termination of coverage report
|
Hebrew (modern) | 174.5 KB | |
| 2021-07-29 21:13 |
Notice of Dividend Amount
Termination of coverage report
|
Russian | 101.2 KB | |
| 2021-06-13 10:10 |
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
|
English | 1.1 MB | |
| 2021-06-13 10:10 |
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
|
Russian | 101.2 KB | |
| 2021-04-11 22:23 |
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
|
English | 1.1 MB | |
| 2021-04-11 22:23 |
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
|
Russian | 98.1 KB | |
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | |
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | |
| 2020-09-01 21:58 |
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | |
| 2020-09-01 21:58 |
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | |
| 2020-08-24 21:06 |
Earnings Release
update analsis (FORST),price target is unchanged
|
English | 1.1 MB | |
| 2020-08-24 21:06 |
Investor Presentation
update analsis (FORST),price target is unchanged
|
Russian | 91.4 KB | |
| 2020-06-10 21:16 |
Investor Presentation
Quarterly analysis update report
|
English | 1.1 MB | |
| 2020-06-10 21:16 |
Investor Presentation
Quarterly analysis update report
|
Russian | 93.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |